Annual FCF
-$8.11 M
-$18.52 M-177.92%
December 31, 2023
Summary
- As of March 6, 2025, OPRX annual free cash flow is -$8.11 million, with the most recent change of -$18.52 million (-177.92%) on December 31, 2023.
- During the last 3 years, OPRX annual FCF has fallen by -$1.68 million (-26.04%).
- OPRX annual FCF is now -177.92% below its all-time high of $10.41 million, reached on December 31, 2022.
Performance
OPRX Free Cash Flow Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly FCF
$1.70 M
+$1.00 M+143.76%
September 30, 2024
Summary
- As of March 6, 2025, OPRX quarterly free cash flow is $1.70 million, with the most recent change of +$1.00 million (+143.76%) on September 30, 2024.
- Over the past year, OPRX quarterly FCF has increased by +$547.00 thousand (+47.48%).
- OPRX quarterly FCF is now -57.68% below its all-time high of $4.01 million, reached on March 31, 2022.
Performance
OPRX Quarterly FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM FCF
-$1.12 M
+$547.00 K+32.80%
September 30, 2024
Summary
- As of March 6, 2025, OPRX TTM free cash flow is -$1.12 million, with the most recent change of +$547.00 thousand (+32.80%) on September 30, 2024.
- Over the past year, OPRX TTM FCF has dropped by -$1.27 million (-832.90%).
- OPRX TTM FCF is now -110.77% below its all-time high of $10.41 million, reached on December 31, 2022.
Performance
OPRX TTM FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Free Cash Flow Formula
FCF = Cash From Operations − CAPEX
OPRX Free Cash Flow Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -177.9% | +47.5% | -832.9% |
| 3 y3 years | -26.0% | +218.5% | -566.9% |
| 5 y5 years | -1256.2% | +183.8% | +65.5% |
OPRX Free Cash Flow Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -177.9% | at low | -57.7% | +131.0% | -110.8% | +86.2% |
| 5 y | 5-year | -177.9% | at low | -57.7% | +131.0% | -110.8% | +86.2% |
| alltime | all time | -177.9% | at low | -57.7% | +131.0% | -110.8% | +86.2% |
OptimizeRx Free Cash Flow History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | $1.70 M(+143.8%) | -$1.12 M(-32.8%) |
| Jun 2024 | - | $697.00 K(-64.5%) | -$1.67 M(-71.4%) |
| Mar 2024 | - | $1.97 M(-135.8%) | -$5.84 M(-28.0%) |
| Dec 2023 | -$8.11 M(-177.9%) | -$5.48 M(-575.8%) | -$8.11 M(-5404.5%) |
| Sep 2023 | - | $1.15 M(-133.2%) | $152.90 K(-93.7%) |
| Jun 2023 | - | -$3.47 M(+1023.6%) | $2.43 M(-60.1%) |
| Mar 2023 | - | -$309.00 K(-111.1%) | $6.09 M(-41.5%) |
| Dec 2022 | $10.41 M(+4237.3%) | $2.78 M(-18.8%) | $10.41 M(+68.1%) |
| Sep 2022 | - | $3.43 M(+1729.0%) | $6.19 M(+120.7%) |
| Jun 2022 | - | $187.30 K(-95.3%) | $2.81 M(+5.0%) |
| Mar 2022 | - | $4.01 M(-380.0%) | $2.67 M(+1013.9%) |
| Dec 2021 | $240.00 K(-103.7%) | -$1.43 M(-3833.3%) | $240.00 K(-124.0%) |
| Sep 2021 | - | $38.40 K(-28.9%) | -$998.50 K(-14.2%) |
| Jun 2021 | - | $54.00 K(-96.6%) | -$1.16 M(+5.9%) |
| Mar 2021 | - | $1.58 M(-159.2%) | -$1.10 M(-82.9%) |
| Dec 2020 | -$6.44 M(+98.1%) | -$2.67 M(+2005.7%) | -$6.44 M(+11.2%) |
| Sep 2020 | - | -$126.90 K(-207.0%) | -$5.79 M(-12.9%) |
| Jun 2020 | - | $118.60 K(-103.2%) | -$6.65 M(-15.7%) |
| Mar 2020 | - | -$3.75 M(+85.3%) | -$7.88 M(+142.6%) |
| Dec 2019 | -$3.25 M(-563.1%) | -$2.03 M(+106.2%) | -$3.25 M(+979.6%) |
| Sep 2019 | - | -$982.80 K(-11.9%) | -$300.90 K(-117.2%) |
| Jun 2019 | - | -$1.12 M(-227.3%) | $1.75 M(-27.1%) |
| Mar 2019 | - | $876.10 K(-4.9%) | $2.40 M(+242.4%) |
| Dec 2018 | $701.50 K(-146.1%) | $921.50 K(-13.7%) | $701.50 K(-734.3%) |
| Sep 2018 | - | $1.07 M(-330.1%) | -$110.60 K(-94.5%) |
| Jun 2018 | - | -$464.10 K(-43.7%) | -$2.01 M(-1.2%) |
| Mar 2018 | - | -$824.00 K(-853.2%) | -$2.03 M(+33.5%) |
| Dec 2017 | -$1.52 M(+86.6%) | $109.40 K(-113.2%) | -$1.52 M(-29.9%) |
| Sep 2017 | - | -$829.50 K(+69.7%) | -$2.17 M(+62.8%) |
| Jun 2017 | - | -$488.70 K(+55.9%) | -$1.33 M(+61.3%) |
| Mar 2017 | - | -$313.40 K(-42.0%) | -$827.00 K(+1.4%) |
| Dec 2016 | -$815.50 K | -$540.00 K(-6935.4%) | -$815.50 K(+236.6%) |
| Sep 2016 | - | $7900.00(-57.3%) | -$242.30 K(+255.8%) |
| Jun 2016 | - | $18.50 K(-106.1%) | -$68.10 K(-240.4%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2016 | - | -$301.90 K(-1009.3%) | $48.50 K(-88.3%) |
| Dec 2015 | $414.10 K(-188.8%) | $33.20 K(-81.8%) | $414.20 K(-27.1%) |
| Sep 2015 | - | $182.10 K(+34.8%) | $567.90 K(+490.3%) |
| Jun 2015 | - | $135.10 K(+111.8%) | $96.20 K(-118.5%) |
| Mar 2015 | - | $63.80 K(-65.9%) | -$519.90 K(+11.5%) |
| Dec 2014 | -$466.30 K(-155.9%) | $186.90 K(-164.5%) | -$466.20 K(+2068.4%) |
| Sep 2014 | - | -$289.60 K(-39.8%) | -$21.50 K(-105.3%) |
| Jun 2014 | - | -$481.00 K(-509.4%) | $402.40 K(-58.7%) |
| Mar 2014 | - | $117.50 K(-81.4%) | $975.40 K(+17.0%) |
| Dec 2013 | $834.00 K(-223.6%) | $631.60 K(+370.3%) | $834.00 K(+308.8%) |
| Sep 2013 | - | $134.30 K(+46.0%) | $204.00 K(-216.4%) |
| Jun 2013 | - | $92.00 K(-484.9%) | -$175.20 K(-67.4%) |
| Mar 2013 | - | -$23.90 K(-1593.8%) | -$537.20 K(-20.4%) |
| Dec 2012 | -$674.90 K(-10.8%) | $1600.00(-100.7%) | -$675.00 K(+0.1%) |
| Sep 2012 | - | -$244.90 K(-9.3%) | -$674.20 K(-23.4%) |
| Jun 2012 | - | -$270.00 K(+67.0%) | -$879.70 K(+11.5%) |
| Mar 2012 | - | -$161.70 K(-6837.5%) | -$788.90 K(+4.3%) |
| Dec 2011 | -$756.40 K(-50.8%) | $2400.00(-100.5%) | -$756.40 K(-6.0%) |
| Sep 2011 | - | -$450.40 K(+151.3%) | -$805.10 K(-5.6%) |
| Jun 2011 | - | -$179.20 K(+38.7%) | -$853.30 K(-38.2%) |
| Mar 2011 | - | -$129.20 K(+179.0%) | -$1.38 M(-10.1%) |
| Dec 2010 | -$1.54 M(-18.1%) | -$46.30 K(-90.7%) | -$1.54 M(-13.1%) |
| Sep 2010 | - | -$498.60 K(-29.5%) | -$1.77 M(+10.4%) |
| Jun 2010 | - | -$707.20 K(+148.1%) | -$1.60 M(+16.5%) |
| Mar 2010 | - | -$285.00 K(+2.8%) | -$1.37 M(-22.3%) |
| Dec 2009 | -$1.88 M(+101.9%) | -$277.30 K(-16.4%) | -$1.77 M(-1.6%) |
| Sep 2009 | - | -$331.70 K(-31.0%) | -$1.80 M(+7.4%) |
| Jun 2009 | - | -$480.70 K(-29.3%) | -$1.67 M(+18.6%) |
| Mar 2009 | - | -$679.90 K(+122.0%) | -$1.41 M(+51.8%) |
| Dec 2008 | -$930.00 K(+116.7%) | -$306.20 K(+47.4%) | -$930.00 K(+49.1%) |
| Sep 2008 | - | -$207.80 K(-4.5%) | -$623.80 K(+50.0%) |
| Jun 2008 | - | -$217.60 K(+9.7%) | -$416.00 K(+109.7%) |
| Mar 2008 | - | -$198.40 K | -$198.40 K |
| Dec 2007 | -$429.20 K | - | - |
FAQ
- What is OptimizeRx annual free cash flow?
- What is the all time high annual FCF for OptimizeRx?
- What is OptimizeRx annual FCF year-on-year change?
- What is OptimizeRx quarterly free cash flow?
- What is the all time high quarterly FCF for OptimizeRx?
- What is OptimizeRx quarterly FCF year-on-year change?
- What is OptimizeRx TTM free cash flow?
- What is the all time high TTM FCF for OptimizeRx?
- What is OptimizeRx TTM FCF year-on-year change?
What is OptimizeRx annual free cash flow?
The current annual FCF of OPRX is -$8.11 M
What is the all time high annual FCF for OptimizeRx?
OptimizeRx all-time high annual free cash flow is $10.41 M
What is OptimizeRx annual FCF year-on-year change?
Over the past year, OPRX annual free cash flow has changed by -$18.52 M (-177.92%)
What is OptimizeRx quarterly free cash flow?
The current quarterly FCF of OPRX is $1.70 M
What is the all time high quarterly FCF for OptimizeRx?
OptimizeRx all-time high quarterly free cash flow is $4.01 M
What is OptimizeRx quarterly FCF year-on-year change?
Over the past year, OPRX quarterly free cash flow has changed by +$547.00 K (+47.48%)
What is OptimizeRx TTM free cash flow?
The current TTM FCF of OPRX is -$1.12 M
What is the all time high TTM FCF for OptimizeRx?
OptimizeRx all-time high TTM free cash flow is $10.41 M
What is OptimizeRx TTM FCF year-on-year change?
Over the past year, OPRX TTM free cash flow has changed by -$1.27 M (-832.90%)